BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 119310)

  • 1. A high frequency of cytotoxic precursor cells for a syngeneic tumour.
    Warren HS; Lafferty KJ
    Scand J Immunol; 1979; 10(4):349-52. PubMed ID: 119310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitro.
    Warren HS; Woolnough JA; Lafferty KJ
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):247-51. PubMed ID: 98140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour.
    Hancock EJ; Kilburn DG
    Cancer Immunol Immunother; 1982; 14(1):54-8. PubMed ID: 6819082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Neoplasma; 1987; 34(4):431-9. PubMed ID: 3116439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of syngeneic and allogeneic lymphoid cells by tumour cells in vitro.
    Potter MR; Balfour BM
    Br J Cancer; 1975 Jul; 32(1):5-15. PubMed ID: 126072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. I. Morphometric assessment of lymph node immunoreactivity and analysis of circulating antibodies.
    Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R
    Exp Pathol; 1986; 30(2):65-74. PubMed ID: 3096773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitro and biological activity in vivo.
    Warren HS; Woolnough JA; Denaro CP; Lafferty KJ
    Adv Exp Med Biol; 1979; 114():757-61. PubMed ID: 111489
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.
    Uyttenhove C; Van Snick J; Boon T
    J Exp Med; 1980 Nov; 152(5):1175-83. PubMed ID: 6776226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin-dependent cell-mediated cytotoxicity: assessment of cytotoxic reactivity following challenge with syngeneic tumors.
    Laux DC; Parker BM; DiSciullo SO; Petrarca MA; McAllister CG
    J Natl Cancer Inst; 1984 Mar; 72(3):667-72. PubMed ID: 6583449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.
    Boon T; Van Snick J; Van Pel A; Uyttenhove C; Marchand M
    J Exp Med; 1980 Nov; 152(5):1184-93. PubMed ID: 6776227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adult thymectomy on tumour immunity in mice.
    Takei F; Levy JG; Kilburn DG
    Br J Cancer; 1978 May; 37(5):723-31. PubMed ID: 306831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-(human LFA-1) monoclonal antibodies bind P815 murine tumour cells.
    Palisson MJ; Altemeyer A; Moosbrugger I; Warter S; Hauptmann G; Bischoff P
    Cancer Immunol Immunother; 1992; 34(6):407-13. PubMed ID: 1373342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic activity of guinea-pig lymph node cells stimulated in vitro.
    Altman A; Rapp HJ
    Int J Cancer; 1978 Nov; 22(5):595-601. PubMed ID: 721319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes.
    Hale AH; Paulus LK
    Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
    Maryanski JL; Van Snick J; Cerottini JC; Boon T
    Eur J Immunol; 1982 May; 12(5):401-6. PubMed ID: 6178607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of activated macrophages with normal and neoplastic cells.
    La Posta VJ; Kotlarski I
    Aust J Exp Biol Med Sci; 1982 Oct; 60 (Pt 5)():513-28. PubMed ID: 6819844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.